Case of carbon-ion radiation recall mucositis associated with anti-programmed cell death 1 treatment for paranasal sinuses melanoma

被引：2
|
作者：
Waki, Yuma [1 ]
Nobeyama, Yoshimasa [1 ]
Katsumata, Fuminori [1 ]
Koto, Masashi [2 ]
Asahina, Akihiko [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Dermatol, Tokyo 1058461, Japan
[2] Natl Inst Radiol Sci, Natl Inst Quantum & Radiol Sci & Technol, Dept Charged Particle Therapy Res, Chiba, Japan
来源：
JOURNAL OF DERMATOLOGY | 2021年 / 48卷 / 10期
关键词：
D O I：
10.1111/1346-8138.16052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E502 / E503
页数：2
相关论文
共 50 条
  • [31] Diffuse hair loss following anti-programmed cell death-1 antibody treatment: a case report with immunohistochemical analysis
    Takayoshi Komatsu-Fujii
    Atsushi Otsuka
    Yoshihiro Ishida
    Yo Kaku
    Chisato Yamashita
    Akitaka Hata
    Tatsuki Kataoka
    Tetsuya Honda
    Kenji Kabashima
    European Journal of Dermatology, 2019, 29 : 326 - 327
  • [32] Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report
    Juan Martin-Liberal
    Andrew JS Furness
    Kroopa Joshi
    Karl S. Peggs
    Sergio A. Quezada
    James Larkin
    Cancer Immunology, Immunotherapy, 2015, 64 : 765 - 767
  • [33] Diffuse hair loss following anti-programmed cell death-1 antibody treatment: a case report with immunohistochemical analysis
    Komatsu-Fujii, Takayoshi
    Otsuka, Atsushi
    Ishida, Yoshihiro
    Kaku, Yo
    Yamashita, Chisato
    Hata, Akitaka
    Kataoka, Tatsuki
    Honda, Tetsuya
    Kabashima, Kenji
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (03) : 326 - 327
  • [34] Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases
    Nardin, Charlee
    Mateus, Christine
    Texier, Mathieu
    Lanoy, Emilie
    Hibat-Allah, Salima
    Ammari, Samy
    Robert, Caroline
    Dhermain, Frederic
    MELANOMA RESEARCH, 2018, 28 (02) : 111 - 119
  • [35] Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum
    Salomon, G.
    Maza, A.
    Boulinguez, S.
    Paul, C.
    Lamant, L.
    Tournier, E.
    Mazereeuw-Hautier, J.
    Meyer, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (05) : 1199 - 1203
  • [36] Anti-Programmed Cell Death-1 (PD-1) Monoclonal Antibodies in Treating Advanced Melanoma - A Clinical Update
    Van Anh Trinh
    Joseph, Jocelyn
    Hwu, Wen-Jen
    DISCOVERY MEDICINE, 2018, 25 (135) : 31 - 40
  • [37] The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
    Ogata, Dai
    Haydu, Lauren E.
    Glitza, Isabella C.
    Patel, Sapna P.
    Tawbi, Hussein A.
    McQuade, Jennifer L.
    Diab, Adi
    Ekmekcioglu, Suhendan
    Wong, Michael K.
    Davies, Michael A.
    Amaria, Rodabe N.
    CANCER MEDICINE, 2021, 10 (07): : 2293 - 2299
  • [38] Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature
    Zhao, Cathy Yunjia
    Hwang, Shelley Ji Eun
    Consuegra, Germana
    Chou, Shaun
    Fernandez-Penas, Pablo
    MELANOMA RESEARCH, 2018, 28 (06) : 491 - 501
  • [39] Anti-programmed death-1 immunotherapy-promising treatment for metastatic colorectal cancer: A case report
    Guo, Tian-Hao
    Hong, Sheng-Wei
    Zhu, Wen-Jian
    Hui, Yi-Fan
    Qiu, Wen-Li
    Wu, Yan
    Li, Xuan
    Ke, Fei
    Li, Liu
    Cheng, Hai-Bo
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (02)
  • [40] Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck Cancer
    Tanaka, Katsunori
    Hirakawa, Hitoshi
    Suzuki, Mikio
    Higa, Teruyuki
    Agena, Shinya
    Hasegawa, Narumi
    Kawakami, Junko
    Toyama, Masatomo
    Higa, Tomoyo
    Kinjyo, Hidetoshi
    Kise, Norimoto
    Kondo, Shunsuke
    Maeda, Hiroyuki
    Ikegami, Taro
    CURRENT ONCOLOGY, 2023, 30 (06) : 5409 - 5424
12345